Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 4,281–4,288 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Viridian Therapeutics Inc. Veligrotug (VRDN-001) - (THRIVE-2) Thyroid Eye Disease (TED) PDUFA priority review Ongoing Intravenous Opthalmic
Viridian Therapeutics Inc. VRDN-001 - (THRIVE) Active Thyroid Eye Disease (TED) PDUFA priority review Ongoing Intravenous Opthalmic
Viridian Therapeutics Inc. VRDN-003 - (REVEAL-2) Chronic Thyroid Eye Disease (TED) Phase 3 Ongoing Intravenous Opthalmic
Viridian Therapeutics Inc. VRDN-003 - (REVEAL-1) Active and Chronic Moderate-to-Severe Thyroid Eye Disease Phase 3 Trial Planned Intravenous Opthalmic
Virpax Pharmaceuticals Inc. Probudur Post-operative pain Phase 2 Data Released Infiltration Non-Opioid Analgesic
Vistagen Therapeutics Inc. PH94B - (PALISADE-4) Social Anxiety Disorder (SAD) Phase 3 Ongoing Intranasal Psychiatric
Vistagen Therapeutics Inc. PH94B - (PALISADE-1) Social Anxiety Disorder (SAD) Phase 3 Trial Completed Intranasal Psychiatric
Vistagen Therapeutics Inc. PH94B - (PALISADE-3) Social Anxiety Disorder (SAD) Phase 3 Data Released Intranasal Psychiatric